Viewing Study NCT01216670



Ignite Creation Date: 2024-05-05 @ 10:55 PM
Last Modification Date: 2024-10-26 @ 10:26 AM
Study NCT ID: NCT01216670
Status: COMPLETED
Last Update Posted: 2015-10-14
First Post: 2010-04-21

Brief Title: Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure
Sponsor: Medtronic Italia
Organization: Medtronic Italia

Study Overview

Official Title: Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure
Status: COMPLETED
Status Verified Date: 2013-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CARRYINGON
Brief Summary: The CARRYING ON for heart failure HF study is a national prospective post market interventional multi-center open-label pilot trialThe purpose of the study is to assess a short term and a long term period incidence of pre-specified clinical and arrhythmic events in patients with a low ejection fraction EF that are hospitalized for acute cardiac decompensation
Detailed Description: The CARRYING ON for heart failure HF study is a national prospective post market interventional multi-center open-label pilot trial designed in two phases

The purpose of the study is to assess a short term 6 months follow-up - Phase 1 and a long term period 24 months follow-up - Phase 2 incidence of pre-specified clinical and arrhythmic events in patients with a low ejection fraction EF that are hospitalized for acute cardiac decompensation A previously implanted Reveal XT device will be used to collect heart rhythm information

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None